Table 1: Pharmacological agents used to treat TBI, their provider, and their potential side-effects.
Stages of brain injury in military personnel and pharmacological interventions thought to be effective against TBI-related comorbidities. Outlined are the benefits of current interventions, their side effects and how TBI polypharmacy, particularly at high dosages, may prevent the recovery of cognitive capacities.
| Condition | Drug | Manufacturer | Side effects |
|---|---|---|---|
| elevated ICP | indomethacin | Merck & Co. | dizziness, fatigue, vertigo, negative renal function (Harrigan, Tuteja et al. 1997) |
| insomnia | benzodiazepine | Roche | dizziness, nausea, headache, non-verbal visual memory impairment (Barker, Greenwood et al. 2004) |
| prazosin | Pfizer | dizziness, weakness, nausea (Koola, Varghese et al. 2014) | |
| hypersomnia | modafinil | Teva Pharmaceutical | headache, nausea (167) |
| PTE | phenytoin | Pfizer | poor cognitive recovery (Bhullar, Johnson et al. 2014) |
| emotional dysregulation | fluoxetine | Eli Lily | delusions, aggression and suicidal ideation (168) |
| methylphenidate | Novartis | insomnia, decreased appetite, headache (169) |